Now Available: Brain Metastasis - Pipeline Review, H2 2012

Sept. 16, 2012 - PRLog -- Global Markets Direct's, 'Brain Metastasis - Pipeline Review, H2 2012', provides an overview of the Brain Metastasis therapeutic pipeline. This report provides information on the therapeutic development for Brain Metastasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Brain Metastasis. 'Brain Metastasis - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/463893_brain_metastasis_pipeline_review_h2_2012.aspx
------------------------------------------------------------

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Brain Metastasis.
* A review of the Brain Metastasis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Brain Metastasis pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Brain Metastasis.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Brain Metastasis pipeline depth and focus of Brain Metastasis therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Brain Metastasis Therapeutic Products under Development, Key Players in Brain Metastasis Therapeutics, Brain Metastasis Pipeline Overview, Brain Metastasis Pipeline, Brain Metastasis Pipeline Assessment

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Brain Metastasis Overview
Therapeutics Development
An Overview of Pipeline Products for Brain Metastasis
Brain Metastasis Therapeutics under Development by Companies
Brain Metastasis Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Brain Metastasis Therapeutics - Products under Development by Companies
Brain Metastasis Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Brain Metastasis Therapeutics Development
Abbott Laboratories
Sanofi-Aventis
YM BioSciences Inc.
Cell Therapeutics, Inc.
Geron Corporation
Spectrum Pharmaceuticals, Inc.
Philogen S.p.A.
to-BBB technologies BV
Brain Metastasis - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
OPAXIO - Drug Profile
Lucanthone - Drug Profile
GRN1005 - Drug Profile
ABT-888 - Drug Profile
Zolinza - Drug Profile
Temozolomide +Vinorelbine - Drug Profile
Lapatinib + Temozolomide - Drug Profile
Sorafenib - Drug Profile
Vorinostat + Radiation Therapy - Drug Profile
Bendamustine + Radiation Therapy - Drug Profile
Bendamustine + Radiation Therapy - Drug Profile
Carboplatin + Bevacizumab + Herceptin - Drug Profile
Lapatinib + Radiation Therapy - Drug Profile
Methotrexate + Liposomal Cytarabine - Drug Profile
memantine hydrochloride - Drug Profile
Gefitinib + Radiation Therapy - Drug Profile
Alimta - Drug Profile
Temozolomide - Drug Profile
Sutent - Drug Profile
Lapatinib + Whole Brain Radiation - Drug Profile
Depakene+ VePesid - Drug Profile
Temozolomide + Radiation Therapy - Drug Profile
BSI-201 + Irinotecan - Drug Profile
Temozolomide - Drug Profile
EMD121974 + Radiation Therapy - Drug Profile
Sutent - Drug Profile
Crixivan + Norvir + Radiation Therapy - Drug Profile
2B3-101 - Drug Profile
Temozolomide - Drug Profile
Erlotinib - Drug Profile
incyclinide - Drug Profile
Theracim + Radiation Therapy - Drug Profile
Erlotinib + Radiotherapy - Drug Profile
Ferumoxytol - Drug Profile
Erlotinib - Drug Profile
Irinotecan Hydrochloride + Radiation Therapy - Drug Profile
Temodar + Radiosurgery - Drug Profile
Iressa - Drug Profile
AZD2171 + Whole Brain Radiation - Drug Profile
Temodal - Drug Profile
polifeprosan 20 with carmustine implant - Drug Profile
everolimus + whole-brain radiation therapy - Drug Profile
Riluzole + Radiation Therapy - Drug Profile
Temozolomide - Drug Profile
Cilengitide - Drug Profile
EGb761 - Drug Profile
Epothilone B - Drug Profile
Irinotecan Hydrochloride - Drug Profile
RO4929097 + Radiation Therapy - Drug Profile
Lapatinib + Whole Brain Radiotherapy - Drug Profile
Bendamustine + Fractionated Stereotactic Radiotherapy - Drug Profile
Paclitaxel + Etoposide + Cisplatin + Radiotherapy - Drug Profile

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=4638...

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.